Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Dermatologic 1

Conditions

Skin Neoplasms 1Sarcoma, Kaposi 1Sarcoma 1Neoplasms 1Muscle Neoplasms 1HIV Infections 1Acquired Immunodeficiency Syndrome 1

Interventions

Specimen Handling 2Semaxinib 2tin etiopurpurin 1pembrolizumab 1montanide ISA 51 1cc-486 1atezolizumab 1Tumor Necrosis Factor-alpha 1Tissue Banks 1SUB1 protein, human 1Ritonavir 1Radiosurgery 1Quality of Life 1Patient Reported Outcome Measures 1Observation 1Nelfinavir 1Molecular Diagnostic Techniques 1Mohs Surgery 1Melphalan 1Interleukin-2 1Interleukin-12 1Injections 1Immunotherapy 1Etoposide 1Drug Therapy 1Cyclophosphamide 1Blood Specimen Collection 1Biopsy 1Biological Therapy 1Azacitidine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Skin Neoplasms × Tumor Necrosis Factor-alpha × Sarcoma × Clear all
NCT00002262 2005-06-24

A Phase I/II Study of Intralesional Recombinant Tumor Necrosis Factor in Patients With AIDS-Related Cutaneous Kaposi's Sarcoma

NIH AIDS Clinical Trials Information Service

Phase 1 Completed
DermatologicSarcoma

Acquired Immunodeficiency Syndrome, Sarcoma, Kaposi, Skin Neoplasms, HIV Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡